Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.
作者信息
Pannuti F, Martoni A, Di Marco A R, Piana E, Saccani F, Becchi G, Mattioli G, Barbanti F, Marra G A, Persiani W, Cacciari L, Spagnolo F, Palenzona D, Rocchetta G
出版信息
Eur J Cancer (1965). 1979 Apr;15(4):593-601. doi: 10.1016/0014-2964(79)90097-5.
PMID:86447
Abstract
摘要
Zotero 插件